PUBLICATION

Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7

Authors
Feng, Y., Zhang, B., Lv, J., Zhang, P., Mao, Q., Lin, F., Zhao, J., Fu, X., Yang, Y., Li, Z., Zhang, L., Mou, Y., Wang, S.
ID
ZDB-PUB-220316-13
Date
2022
Source
European Journal of Medicinal Chemistry   234: 114254 (Journal)
Registered Authors
Keywords
Autophagy, Celastrol, MCF-7, Scaffold hopping
MeSH Terms
  • Animals
  • Antineoplastic Agents*/chemistry
  • Apoptosis
  • Autophagy
  • Breast Neoplasms*/drug therapy
  • Breast Neoplasms*/pathology
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • MCF-7 Cells
  • Oxazoles/pharmacology
  • Pentacyclic Triterpenes
  • Pyrazines/pharmacology
  • Structure-Activity Relationship
  • Zebrafish/metabolism
PubMed
35290844 Full text @ Eur. J. Med. Chem.
Abstract
Three series of celastrol derivatives, namely, 6a-6i, 11a-11i and 15a-15i, were designed based on the scaffold hopping strategy. The derivatives were synthesized and biologically evaluated against five human tumor cell lines (i.e. A549, MCF-7, Bel7402, HT-29 and PC3) using MTT assay in vitro. Results showed that compound 11i exhibited apparent antiproliferative activity against the MCF-7 cell line with an IC50 value of 1.31 μM and could remarkably inhibit the colony formation of the MCF-7 cells. Transmission electron microscopy assay, monodansylcadaverine incorporation assay and the expression of LC3 A/B, p62 and Beclin-1 in MCF-7 cells suggested that the potent antiproliferative activity of compound 11i was mainly due to its autophagy-inducing effect. Moreover, compound 11i could arrest the MCF-7 cells in the G2/M phase by regulating the cell-cycle-related proteins Cdk-1 and Cyclin B1. In the zebrafish xenograft model, compound 11i could obviously inhibit the proliferation of the MCF-7 cells. Thus, compound 11i could serve as a promising lead compound for breast cancer therapy.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping